Company profilePharmaceutical#581 of 1,318 in Pakistan✓ No DRAP alerts

FORAY PHARMACEUTICALS

Pharmaceutical company · 20 brands · 26 molecules

Ranked #6 of 57 companies in Vitamin A, D & Combinations

20 registered products 16 pharmaceutical brands 26 distinct molecules 0 DRAP alerts

Company overview

20
registered products
16
pharmaceutical brands
26
distinct molecules
12
therapeutic classes
0
DRAP alerts

FORAY PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 20 product registrations across 26 distinct molecules. Its portfolio is concentrated in Vitamin A, D & Combinations and Angiotensin-Ii Antagonists, Combinations. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Losartan2 brands
Tizanidine2 brands
Escitalopram2 brands
Losartan Potassium ...... 50 Mg1 brand
Losartan Potassium ...... 25 Mg1 brand
Itopride1 brand

Therapeutic classes

Vitamin A, D & Combinations · 3Angiotensin-Ii Antagonists, Combinations · 2Muscle Relaxant · 2Antidepressants · 2Antiemetics & Antinauseants · 2Enzymes To Treat Inflammatory Condition · 1Antihistamines For Systemic Use · 1Pain Management · 1Antiinflammatory And Antirheumatic Products · 1Antivirals For Systemic Use · 1Blood Glucose Lowering Drugs, Excluding Insulin · 1Drugs For Benign Prostatic Hypertrophy · 1

Conditions treated

Pain Killers · 1General Infections · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official2 products · Rs 231.29 – Rs 420.53
Servaid2 products · Rs 235 – Rs 325
Median across source: Rs 325.91

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

HIGH - Q INTERNATIONAL14 shared molecules
BIO LABS (PVT) LTD.13 shared molecules
SHROOQ PHARMACEUTICALS13 shared molecules
SEARLE PAKISTAN (PVT.) LTD.12 shared molecules
LINTA12 shared molecules

Get the full profile for FORAY

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.